Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | SLC6A1 | P30531 | 4/20 | 0.33 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.33 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.33 |
| ▸ | CPN1 | P15169 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | GLB1 | P16278 | 2/20 | 0.31 |
| ▸ | GBA1 | P04062 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL22341588 | 0.98 | CXCR4 (0.39) | CXCR4SMN1; SMN2SLC6A1SLC6A11SLC6A13 | |
| Water SCHEMBL20504445 | 0.91 | ALDH1A1 (0.38) | CXCR4SMN1; SMN2SLC6A1SLC6A11SLC6A13 | |
| SCHEMBL2913805 | 0.91 | SLC6A1 (0.38) | SLC6A1SLC6A11SLC6A13GABRA5GABRB2 | |
| SCHEMBL9594707 | 0.84 | NAAA (0.36) | CXCR4SMN1; SMN2KMT2AHRH3 | |
| SCHEMBL967366 | 0.82 | — | — | |
| SCHEMBL5509027 | 0.82 | — | — | |
| SCHEMBL13285747 | 0.82 | — | — | |
| SCHEMBL30969422 | 0.81 | CXCR4 (0.45) | CXCR4SMN1; SMN2SLC6A1SLC6A11SLC6A13 | |
| Hydrochloric Acid SCHEMBL20590882 | 0.80 | KMT2A (0.46) | SMN1; SMN2SLC6A1SLC6A11SLC6A13GABRA5 | |
| SCHEMBL5472349 | 0.80 | KMT2A (0.42) | SMN1; SMN2SLC6A1SLC6A11SLC6A13GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2780333-B1 | METHODS FOR PREPARING FUNCTIONAL TETRAAZACYCLOALKANE COMPOUNDS USING A SPECIFIC CYCLIC BISAMINAL COMPOUND | UNIV BRETAGNE OCCIDENTALE (FR) | 2018-05-30 | — | — | EP | disclosed |
| US-9315511-B2 | Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2016-04-19 | — | — | US | disclosed |
| US-9315511-B2 | Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2016-04-19 | — | — | US | disclosed |
| US-20140323717-A1 | Methods for Preparing Functional Tetraazacycloalkane Compounds using a Specific Cyclic Bisaminal Compound | CNRS-CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-10-30 | — | — | US | disclosed |
| US-20140323717-A1 | Methods for Preparing Functional Tetraazacycloalkane Compounds using a Specific Cyclic Bisaminal Compound | CNRS-CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-10-30 | — | — | US | disclosed |
| WO-2013072491-A1 | METHODS FOR PREPARING FUNCTIONAL TETRAAZACYCLOALKANE COMPOUNDS USING A SPECIFIC CYCLIC BISAMINAL COMPOUND | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2013-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323717-A1 | Methods for Preparing Functional Tetraazacycloalkane Compounds using a Specific Cyclic Bisaminal Compound | NISCH, FHIT, FLNB | CXCR4 1404/4885SMN1; SMN2 1463/4885SLC6A1 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.